Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review

被引：0
作者：
Mohsen Imenshahidi
Golamreza Karimi
Hossein Hosseinzadeh
机构：
[1] Mashhad University of Medical Sciences,Department of Pharmacodynamics and Toxicology, School of Pharmacy
[2] Mashhad University of Medical Sciences,Pharmaceutical Research Center, Pharmaceutical Technology Institute
来源：
Naunyn-Schmiedeberg's Archives of Pharmacology | 2020年 / 393卷
关键词：
Cardiovascular risk factors; Melatonin; Hypertension; Diabetes; Obesity; Metabolic syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Melatonin, as a neuroendocrine hormone, is produced primarily by the pineal gland. Melatonin, a pleotropic molecule, acts as a free radical scavenger, antioxidant, and regulator of circadian rhythm in mammals via several receptor-mediated and non-receptor-mediated mechanisms. This inexpensive, well-tolerated, and multi-target molecule has a great therapeutic potential against many diseases. Many evidences have proposed that melatonin plays a key role in the pathophysiology of various cardiovascular diseases. The aim of this paper is to discuss the data and experiments regarding the effects of melatonin in management of cardiovascular risk factors. PubMed, EMBASE, and Scopus have been searched for data collection using related keywords. Two hundred ten articles were included in this review from 2253 founded documents. Using these documents, the main mechanisms of action of melatonin are discussed and summarized in this article. Also, recent progresses regarding melatonin’s effects on cardiovascular risk factors and diseases including diabetes, hypertension, hyperlipidemia, obesity, myocardial ischemia-reperfusion injury, pulmonary hypertension, and atherosclerosis have been reviewed. Many studies have demonstrated the beneficial effects of melatonin in prevention and improving cardiovascular risk factors, and this inexpensive and well-tolerated drug can be strongly proposed in different cardiovascular diseases as well as metabolic syndrome.
引用
收藏
页码：521 / 536
页数：15
相关论文
共 893 条
[11]  
Tabrizi Reza(2014)Melatonin secretion is impaired in women with preeclampsia and an abnormal circadian blood pressure rhythm Ren Fail 36 1001-1007
[12]  
Keshtkaran Zahra(1995)Impaired nocturnal secretion of melatonin in coronary heart disease Lancet 345 1408-99
[13]  
Reiter Russel J.(1994)The role of serotonin and melatonin in gastrointestinal physiology: ontogeny, regulation of food intake, and mutual serotonin-melatonin feedback J Pineal Res 16 91-132
[14]  
Asemi Zatollah(2013)The effects of different doses of melatonin on lipid peroxidation in diet-induced hypercholesterolemic rats Bratisl Med J 114 129-378
[15]  
Allagui MS(1994)Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis Endocrinology 135 373-397
[16]  
Hachani R(2017)Inflammaging, metabolic syndrome and melatonin: a call for treatment studies Neuroendocrinology 104 382-137
[17]  
Saidi S(2014)Melatonergic drugs in development Clin Pharmac 6 127-3280
[18]  
Feriani A(2018)Melatonin receptors: molecular pharmacology and signalling in the context of system bias Br J Pharmacol 175 3263-82
[19]  
Murat JC(2014)Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up J Physiol Pharmacol 65 75-104
[20]  
Kacem K(2015)Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits Mol Med Rep 11 99-381
12345678910